• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Neurology Classics

The OVIVA trial: Oral versus intravenous antibiotics for bone and joint infection [Classics Series]

byDeepti Shroff Karhade
September 14, 2022
in Neurology Classics, The Classics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials

1. This randomized, controlled trial found that oral antibiotics were noninferior to intravenous antibiotics for treatment failure at 1 year when started within 6 weeks of complex orthopedic infections.

2. There was no significant difference in the rate of major adverse events between the two groups.

Original Date of Publication: February 1991

Study Rundown: The Oral Versus Intravenous Antibiotics for Bone and Joint Infection (OVIVA) trial was a multicenter, randomized controlled trial assessing noninferiority for risk of treatment failure at 1 year for oral versus intravenous antibiotics. Overall, oral antibiotics were shown to be noninferior to intravenous antibiotics when initiated within 6 weeks of surgery (risk difference = -1.4). Likewise, there were no significant differences in the percentage of participants with at least one serious adverse event (p = 0.58). Notably, median hospital stay was significantly longer in the intravenous (14 days) versus oral (11 days) groups (p < 0.001). Based on these results, the authors support the use of oral antibiotics in the early treatment of complex orthopedic infections, however they acknowledge this may not be appropriate for all patient groups. Some strengths of this trial were its diverse patient population, with good generalizability, and high trial retention. Limitations, however, included its open-label nature. The trial did not actually assess or compare specific antibiotic agents versus others, relying on local expertise to decide. Finally, given that the trial’s selection criteria were so inclusive and heterogenous, this makes drawing more nuanced conclusions about its population difficult.

Click to read the study in NEJM

RELATED REPORTS

Poor communication closely associated with patient safety incidents

#VisualAbstract: Infrequent Zoledronate over 10 years Prevents Frcatures in Early Postmenopausal Women

#VisualAbstract: Site-Specific Therapy Guided by a 90-Gene Expression Assay Improved Survival in Patients with Cancer of Unknown Primary

In-Depth [randomized controlled trial]: The OVIVA trial was conducted at 26 sites in the United Kingdom, including a per-protocol analysis of 909 participants with complex bone or joint infections. The majority (60.6%) were treated with surgical intervention, and antibiotic treatment was initiated within 6 weeks of presentation in all cases. The difference in the risk of treatment failure between oral and intravenous antibiotics at 1 year was -1.4 percentage points, meeting the prespecified noninferiority criteria. The number of participants experiencing at least one serious adverse event did not differ between groups, and adverse events were most commonly related to operative site or antibiotic-related. Episodes of C. difficile diarrhea also did not significantly differ between groups. Median hospital stay was significantly longer for the intravenous group (14 days) versus the oral group (11 days) (p < 0.001). Patient-reported outcome measures did not significantly differ.

Li H-K, Rombach I, Zambellas R, Walker AS, McNally MA, Atkins BL, et al. Oral versus Intravenous Antibiotics for Bone and Joint Infection. New England Journal of Medicine. 2019 Jan 31;380(5):425–36.

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

Tags: adverse eventsintravenous antibioticsjoint infectionorthopedics
Previous Post

Race and insurance status may affect amblyopia treatment outcomes

Next Post

Individuals with autoimmune diseases may have an increased risk for cardiovascular diseases

RelatedReports

Shared decision-making may be limited in PICU end-of-life discussions
Public Health

Poor communication closely associated with patient safety incidents

April 15, 2025
#VisualAbstract: Infrequent Zoledronate over 10 years Prevents Frcatures in Early Postmenopausal Women
StudyGraphics

#VisualAbstract: Infrequent Zoledronate over 10 years Prevents Frcatures in Early Postmenopausal Women

January 22, 2025
#VisualAbstract: Site-Specific Therapy Guided by a 90-Gene Expression Assay Improved Survival in Patients with Cancer of Unknown Primary
StudyGraphics

#VisualAbstract: Site-Specific Therapy Guided by a 90-Gene Expression Assay Improved Survival in Patients with Cancer of Unknown Primary

August 20, 2024
#VisualAbstract: Early Weight-Bearing Improves Outcomes in Surgically Treated Ankle Fractures Compared to Delayed Weight-Bearing
StudyGraphics

#VisualAbstract: Early Weight-Bearing Improves Outcomes in Surgically Treated Ankle Fractures Compared to Delayed Weight-Bearing

July 4, 2024
Next Post
Long-term outcomes for off-pump and on-pump CABG are similar

Individuals with autoimmune diseases may have an increased risk for cardiovascular diseases

Significant amount of unhealthy children’s foods marketed to parents

Artificial sweetener intake and association with cardiovascular disease risk

Paternal factors associated with short interpregnancy interval

Machine learning tools to predict threatened miscarriage in first trimester

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Dapagliflozin may improve outcomes in patients with metabolic dysfunction-associated steatohepatitis
  • Early induction of labour reduces shoulder dystocia rates in large for gestational age fetuses
  • Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.